Sunwoo Kim is a seasoned investment and business development professional with over 15 years of experience in the biopharmaceutical industry. In 2023, he took on the role of Head of Business Development at Neuracle Genetics, where he is responsible for establishing and maintaining relationships with key stakeholders, including potential partners and investors, to identify and engage in business development opportunities. Sunwoo is also a Partner and Healthcare Portfolio Manager at QUAD Investment Management, where he has demonstrated his expertise in sourcing and investing in private and public biopharmaceutical companies across different therapeutic areas and modalities. Additionally, he oversees QUAD Capital Management US, based in New York. Sunwoo holds a Master of Biotechnology Enterprise and Entrepreneurship in Legal and Regulatory from Johns Hopkins University.